MedPath

Study about efficacy and tolerance of acetate free biofiltration (AFB) in dialysis patients:clinical significance of acetate free and acidisis correction.(NABI study:Nagoya acetate free biofiltration study)

Not Applicable
Conditions
Dysdialysis syndrome
Registration Number
JPRN-UMIN000000827
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

(1)blood disease, malignant disorder, severe liver disorder (2) uses steroid, immunosuppression agent (3) 20 years or older. (4) participating in another clinical trial for 12 weeks or longer. (5) pregnant, during the nursing, possibly pregnant and having the hope of child bearing. (6)judged inappropriate as study subject by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath